Literature DB >> 21810410

Nanog-induced dedifferentiation of p53-deficient mouse astrocytes into brain cancer stem-like cells.

Jai-Hee Moon1, Suhyun Kwon, Eun Kyoung Jun, Aeree Kim, Kwang Youn Whang, Hyunggee Kim, Sejong Oh, Byung Sun Yoon, Seungkwon You.   

Abstract

Self-renewal, differentiation, and tumorigenicity characterize cancer stem cells (CSCs), which are rare and maintained by specific cell fate regulators. CSCs are isolated from glioblastoma multiforme (GBM) and may be responsible for the lethality of incurable brain tumors. Brain CSCs may arise from the transformation of undifferentiated, nestin-positive neural stem or progenitor cells and GFAP-expressing astrocytes. Here, we report a role of Nanog in the genesis of cancer stem-like cells. Using primary murine p53-knockout astrocytes (p53(-/-) astrocytes), we provide evidence that enforced Nanog expression can increase the cellular growth rate and transform phenotypes in vitro and in vivo. In addition, Nanog drives p53(-/-) astrocytes toward a dedifferentiated, CSC-like phenotype with characteristic neural stem cell/progenitor marker expression, neurosphere formation, self-renewal activity, and tumor development. These findings suggest that Nanog promotes dedifferentiation of p53-deficient mouse astrocytes into cancer stem-like cells by changing the cell fate and transforming cell properties.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21810410     DOI: 10.1016/j.bbrc.2011.07.070

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

Review 1.  Translational potential of astrocytes in brain disorders.

Authors:  Alexei Verkhratsky; Luca Steardo; Vladimir Parpura; Vedrana Montana
Journal:  Prog Neurobiol       Date:  2015-09-16       Impact factor: 11.685

Review 2.  Dedifferentiation: inspiration for devising engineering strategies for regenerative medicine.

Authors:  Yongchang Yao; Chunming Wang
Journal:  NPJ Regen Med       Date:  2020-07-31

Review 3.  Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions.

Authors:  Collene R Jeter; Tao Yang; Junchen Wang; Hsueh-Ping Chao; Dean G Tang
Journal:  Stem Cells       Date:  2015-05-13       Impact factor: 6.277

Review 4.  p53 and Cell Fate: Sensitizing Head and Neck Cancer Stem Cells to Chemotherapy.

Authors:  Christie Rodriguez-Ramirez; Jacques E Nör
Journal:  Crit Rev Oncog       Date:  2018

Review 5.  FAK and Nanog cross talk with p53 in cancer stem cells.

Authors:  Vita M Golubovskaya
Journal:  Anticancer Agents Med Chem       Date:  2013-05       Impact factor: 2.505

Review 6.  NANOG: a promising target for digestive malignant tumors.

Authors:  Ai-Xi Sun; Chang-Jiang Liu; Zi-Qin Sun; Zhi Wei
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 7.  Exploiting metabolic differences in glioma therapy.

Authors:  Francesca Galeffi; Dennis A Turner
Journal:  Curr Drug Discov Technol       Date:  2012-12

Review 8.  Glial progenitors as targets for transformation in glioma.

Authors:  Shirin Ilkhanizadeh; Jasmine Lau; Miller Huang; Daniel J Foster; Robyn Wong; Aaron Frantz; Susan Wang; William A Weiss; Anders I Persson
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

9.  Nanog: a potential biomarker for liver metastasis of colorectal cancer.

Authors:  Feng Xu; Chaoliu Dai; Rui Zhang; Yang Zhao; Songlin Peng; Changjun Jia
Journal:  Dig Dis Sci       Date:  2012-05-06       Impact factor: 3.199

10.  The synergistic effect of 5Azadc and TSA on maintenance of pluripotency of chicken ESCs by overexpression of NANOG gene.

Authors:  Xiaoyan Wang; Yingjie Wang; Qisheng Zuo; Dong Li; Wenhui Zhang; Chao Lian; Beibei Tang; Tianrong Xiao; Man Wang; Kehua Wang; Bichun Li; Yani Zhang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-01-28       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.